WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Bayer

The Bayer GroupBayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed 118,900 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion.

www.bayer.com.

Bayer RSS Channel

Filters
List of articles in category Bayer
Title Published Date
Bayer submits first-in-class estradiol-based oral contraceptive for approval in the US 09 July 2009
Bayer files patent infringement lawsuit against Teva 02 July 2009
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets 30 June 2009
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung Cancer 02 June 2009
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung Cancer 02 June 2009
Phase III Trial Started to Evaluate Combination Therapy of Nexavar® and Tarceva® 29 May 2009
Nexavar® Approved in Japan for the Treatment of Advanced Liver Cancer 21 May 2009
Qlaira® - innovative estradiol-based oral contraceptive available in Europe 15 May 2009
Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch 07 May 2009
Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors 30 April 2009
Bayer Crop Science and the French research organization CNRS intensify collaboration 31 March 2009
New image of therapy for erectile difficulties 20 March 2009
Advances in Renal Cancer Journalists' Award 27 February 2009
Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center 12 February 2009
Bayer innovations provide solutions for the global challenges of the future 15 December 2008
Bayer Schering Pharma expands men's healthcare portfolio 05 December 2008
Bayer's Xarelto® Shows Encouraging Results in Patients with Acute Coronary Syndrome 11 November 2008
European Journalists' Prize 2008 announced by Bayer HealthCare 14 October 2008
Bayer Reports Progress in Clinical Program for Riociguat 06 October 2008
Bayer starts new research cooperation in Asia 30 September 2008
  • Start
  • Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • End

Business & Industry

  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design

Research & Development

  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19
  • Scientists develop new biomimetic formulation for treating glioblastoma
  • SARS-CoV-2 hijacks nanotubes between neurons to infect them

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Bayer
  4. Bayer Consumer Health leaders propose new principles for science-led self-care

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.